Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Biocon Limited
Pfizer
Pfizer
Immorna Biotherapeutics, Inc.
Dragonfly Therapeutics
Merck Sharp & Dohme LLC
Centre Oscar Lambret
ViroMissile, Inc.
Replimune Inc.
Pfizer
Tizona Therapeutics, Inc
Werewolf Therapeutics, Inc.
ModernaTX, Inc.
Adaptimmune
Conjupro Biotherapeutics, Inc.
AbbVie
AgonOx, Inc.
UNC Lineberger Comprehensive Cancer Center
Novartis
OncoNano Medicine, Inc.
Degron Therapeutics Co.
Memorial Sloan Kettering Cancer Center
AstraZeneca
Nested Therapeutics, Inc
Tesaro, Inc.
Pfizer
Kyowa Kirin Co., Ltd.
Chiome Bioscience Inc.
Pfizer
UNC Lineberger Comprehensive Cancer Center
JS InnoPharm, LLC
Pfizer
University of Pittsburgh
DEKA Biosciences
Scholar Rock, Inc.
Revolution Medicines, Inc.
Tvardi Therapeutics, Incorporated
GlaxoSmithKline
Checkpoint Therapeutics, Inc.
Altor BioScience
Eli Lilly and Company
Vincerx Pharma, Inc.
Astellas Pharma Inc
National Cancer Institute (NCI)
University of California, San Diego
TuHURA Biosciences, Inc.
Rockefeller University
R-Pharm
AO GENERIUM